ALNY Stock Analysis: Buy, Sell, or Hold?
ALNY - Alnylam Pharmaceuticals, Inc.
$236.01
-0.21 (-0.09%)
âŧ
5d:
+5.08%
30d:
-13.16%
90d:
-20.66%
WAIT
LOW Confidence
Analysis Updated: Aug 24, 2026 12:00 AM ET
Earnings: Jul 30, 2026
0d
Get Alerted When ALNY Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
âšī¸ NEUTRAL: ALNY is fairly priced but lacks strong directional signals. At -9.2% expected growth, valuation appears cheap. Wait for clearer setup or better entry on dips.
âšī¸ NEUTRAL: ALNY is fairly priced but lacks strong directional signals. At -9.2% expected growth, valuation appears cheap. Wait for clearer setup or better entry on dips.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$612.79
Based on 14.5% avg growth
INTRINSIC VALUE TODAY
$380.50
38.0% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: ALNY is currently trading at $236.01, which is considered fair relative to its 30-day fair value range of $216.03 to $268.63. From a valuation perspective, the stock is trading at a discount (Forward PE: 18.8) compared to its historical average (25.0). Remarkably, the market is currently pricing in an annual earnings decline of 9.2% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, ALNY is in a strong downtrend. Immediate support is located at $216.50, while resistance sits at $244.03.
Market Sentiment: ALNY scores 65/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $370.20 (+56.9%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, ALNY is in a strong downtrend. Immediate support is located at $216.50, while resistance sits at $244.03.
Market Sentiment: ALNY scores 65/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $370.20 (+56.9%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$216.03 -
$268.63
Company Quality Score
42/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
83.3%
Protect Your Profits
Holding ALNY? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- NEUTRAL: Price in fair range
- BULLISH: Strong technical setup (65/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 56.9% below Wall St target ($370.20)
- WARNING: Composite score 42/100 in the bottom quintile â this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$216.03 -
$268.63
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$216.50
Resistance Level
$244.03
Current Trend
Strong Downtrend
Technical data as of
Aug 24, 2026
Fundamental Context
Forward P/E (Next Year Est.)
18.75
Wall Street Target
$370.20
(+56.9%)
Revenue Growth (YoY)
66.9%
Profit Margin
16.1%
Valuation Discount vs History
-9.2% cheaper
PE vs Historical
18.8 vs 25.0
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-9.2%
(market-implied from PE analysis)
1-Year Target
$214.30
(-9%)
2-Year Target
$194.58
(-18%)
3-Year Target
$176.68
(-25%)
3-Yr Target (if PE normalizes)
(PE: 19â25)
$235.57
(0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 20.1, Growth: 41.2%)
$710.25
(+201%)
Base:
(SPY PE: 18.8, Growth: 41.2%)
$664.19
(+181%)
Bear:
(PE: 15.9, Growth: 41.2%)
$564.57
(+139%)
đ
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (41x PE), but valuation improves significantly next year (19x PE) as earnings recover.
Trailing PE: 41.15 | Current EPS (TTM): $5.74
Bull Case
$519.68
(+120%)
Analyst growth 100.0%, PE expands to 45.3
Base Case
$472.44
(+100%)
Market implied 100.0%, PE stable at 41.2
Bear Case
$160.63
(-32%)
Severe decline -20.0%, PE contracts to 35.0
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
đĄ
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 18.8 to 25.0
Stabilization Target:
$314.68
(+33.3%)
PE Expansion Potential:
+33.3%
Share & Embed Analysis
Last updated: August 24, 2026 6:31 PM ET
Data refreshes hourly during market hours. Next update: 7:31 PM
Data refreshes hourly during market hours. Next update: 7:31 PM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ALNY showing a specific setup today?
Insider Activity (6 Months)
0
Buys
9
Sells
Net
INSIDERS SELLING
Recent Transactions
Melissa Mclaughlin
SELL
2286 shares
2026-04-06
Melissa Mclaughlin
SELL
1624 shares
2026-04-02
Kevin Joseph Fitzgerald
SELL
1652 shares
2026-03-03
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ONC
BeiGene, Ltd. |
STRONG BUY
24 analysts |
$433 | 38 SELL |
|
VRTX
Vertex Pharmaceuticals IâĻ |
BUY
34 analysts |
$560 | 30 SELL |
|
ASND
Ascendis Pharma AS |
STRONG BUY
16 analysts |
$313 | 50 HOLD |
|
APLS
Apellis Pharmaceuticals âĻ |
BUY
22 analysts |
$41 | 50 HOLD |
|
VERA
Vera Therapeutics Inc |
STRONG BUY
14 analysts |
$77 | 49 HOLD |
Advanced ALNY Option Strategies
Professional options setups generated by AI based on today's ALNY price and gamma walls.
